8.56
전일 마감가:
$8.73
열려 있는:
$8.63
하루 거래량:
661.65K
Relative Volume:
0.34
시가총액:
$1.08B
수익:
-
순이익/손실:
$-174.61M
주가수익비율:
-4.3452
EPS:
-1.97
순현금흐름:
$-165.54M
1주 성능:
+15.74%
1개월 성능:
+48.44%
6개월 성능:
-7.20%
1년 성능:
-7.10%
89 Bio Inc Stock (ETNB) Company Profile
명칭
89 Bio Inc
전화
(415) 432-9270
주소
655 MONTGOMERY STREET, SAN FRANCISCO, CA
ETNB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ETNB
89 Bio Inc
|
8.56 | 1.08B | 0 | -174.61M | -165.54M | -1.97 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
502.98 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
606.99 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
655.08 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
271.20 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
255.22 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-14 | 개시 | Goldman | Neutral |
2025-03-13 | 개시 | Citigroup | Buy |
2025-02-04 | 개시 | Wolfe Research | Outperform |
2024-04-22 | 재개 | BofA Securities | Buy |
2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2023-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2023-08-28 | 개시 | UBS | Buy |
2023-06-13 | 개시 | Evercore ISI | Outperform |
2022-05-12 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2021-12-20 | 개시 | H.C. Wainwright | Buy |
2021-10-26 | 재개 | Cantor Fitzgerald | Overweight |
2021-07-29 | 재개 | BTIG Research | Buy |
2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2021-04-21 | 개시 | Cantor Fitzgerald | Overweight |
2020-10-19 | 개시 | Raymond James | Strong Buy |
2020-09-25 | 업그레이드 | BofA Securities | Neutral → Buy |
2020-07-31 | 개시 | Piper Sandler | Overweight |
2020-07-23 | 개시 | BTIG Research | Buy |
2020-07-07 | 개시 | Chardan Capital Markets | Buy |
2019-12-09 | 개시 | BofA/Merrill | Neutral |
2019-12-09 | 개시 | Oppenheimer | Outperform |
2019-12-09 | 개시 | RBC Capital Mkts | Outperform |
2019-12-09 | 개시 | SVB Leerink | Outperform |
모두보기
89 Bio Inc 주식(ETNB)의 최신 뉴스
Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World
Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus
89bio, Inc. SEC 10-Q Report - TradingView
89bio Inc [NASDAQ: ETNB] Sees Increase in Stock Value - knoxdaily.com
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight - Investing.com
89bio (ETNB) Poised for Success with Advancements in MASH Trials - GuruFocus
Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to “Strong-Buy” - Defense World
89bio Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
There is no doubt that 89bio Inc (ETNB) ticks all the boxes. - Sete News
Insider’s View: Deciphering 89bio Inc (ETNB)’s Financial Health Through Ratios - DWinneX
Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade - knoxdaily.com
Legal & General Group Plc Sells 4,860 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Trimmed by Russell Investments Group Ltd. - Defense World
89bio’s (ETNB) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
89bio Inc [ETNB] stock for 91,208 USD was sold by Le-Nguyen Quoc - knoxdaily.com
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Market Watch: 89bio Inc (ETNB)’s Noteworthy Gain, Closing at 6.55 - DWinneX
A look into 89bio Inc (ETNB)’s deeper side - Sete News
89bio Sees Unusually Large Options Volume (NASDAQ:ETNB) - Defense World
A year in review: 89bio Inc (ETNB)’s performance in the last year - uspostnews.com
Federated Hermes Inc. Acquires 4,236 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Geode Capital Management LLC Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
89bio’s chief technical operations officer sells $91,207 in stock By Investing.com - Investing.com India
89bio’s chief technical operations officer sells $91,207 in stock - Investing.com
89bio: Primary Asset Targeting 2 Potential Indications; In Late-Stage Development (ETNB) - Seeking Alpha
Vanguard Group Inc. Grows Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by Wellington Management Group LLP - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 3,141 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
KLP Kapitalforvaltning AS Purchases New Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Looking For A Good Stock? Let This 89bio Inc (NASDAQ: ETNB) Analysis Help. - stocksregister.com
89bio stock hits 52-week low at $5.96 amid market challenges - Investing.com Canada
89bio stock hits 52-week low at $5.96 amid market challenges By Investing.com - Investing.com South Africa
Teacher Retirement System of Texas Has $191,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Swiss National Bank Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Warrants of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - MarketScreener
Raymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Certain Common Stock of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - marketscreener.com
Are 89bio Inc (NASDAQ: ETNB) Analysts Predicting A Spike? - Stocks Register
Victory Capital Management Inc. Acquires 1,437 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
PNC Financial Services Group Inc. Increases Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Given Sell (D-) Rating at Weiss Ratings - Defense World
89bio, Inc. (NASDAQ:ETNB) Stock Holdings Lifted by Bank of New York Mellon Corp - Defense World
Akero exec calls FDA's accelerated approval guidance for MASH drugs 'bizarre' - Endpoints News
89bio, Inc. (NASDAQ:ETNB) Receives $27.56 Average Target Price from Analysts - Defense World
89 Bio Inc (ETNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):